Workflow
Thermo Fisher Scientific(TMO)
icon
Search documents
J.P. Morgan 42nd Annual Healthcare Conference
2024-01-10 05:23
Marc N. Casper Chairman, President and Chief Executive Officer Please note that the attached presentations contain financial projections and other forward-looking statements that are specific to the date of the presentation and should not be considered current after such date. • Incredibly well-positioned industry leader serving very attractive end markets • We have an outstanding track record of financial performance and an excellent long-term outlook abservices 4 Industry-leading scale Unmatched depth of ...
Thermo Fisher Scientific, Inc. (TMO) 42nd Annual J.P. Morgan Healthcare Conference Transcript
2024-01-09 19:28
Thermo Fisher Scientific, Inc. (NYSE:TMO) 42nd Annual J.P. Morgan Healthcare Conference January 9, 2023 11:15 AM ET Company Participants Marc Casper – Chief Executive Officer Conference Call Participants Rachel Vatnsdal – J.P. Morgan Rachel Vatnsdal Perfect. Good morning everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team here at J.P. Morgan. I'm joined on stage by Marc Casper, CEO of Thermo Fisher. So as we typically do, this is going to be a 40 minute session. First of it, h ...
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
Businesswire· 2024-01-04 13:00
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the “Buyer”), has extended the expiration time of the offering period of its previously announced tender offer (the “Offer”) to acquire all of the outstanding common shares (“Shares”) and all of the outstanding American Depositary Shares, each representing one Share (“ADSs” and, together with the Shares, the “Offe ...
Thermo Fisher Scientific to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
Businesswire· 2024-01-03 13:00
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 11:15 a.m. (EST). You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in servi ...
Thermo Fisher Scientific(TMO) - 2023 Q3 - Quarterly Report
2023-11-02 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2023 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 THERMO FISHER SCIENTIFIC INC. (Exact name of Registrant as specified in its charter) Delaware 04-2209186 (State of incorporation) (I.R.S. Employer Identification No.) 168 Third Avenue Waltham, Mas ...
Thermo Fisher Scientific(TMO) - 2023 Q3 - Earnings Call Transcript
2023-10-25 16:21
Thermo Fisher Scientific Inc. (NYSE:TMO) Q3 2023 Earnings Call Transcript October 25, 2023 8:30 AM ET Company Participants Rafael Tejada - VP of IR Marc Casper - Chairman, President and CEO Stephen Williamson - SVP and CFO Conference Call Participants Jack Meehan - Nephron Research Dan Brennan - TD Cowen Derik de Bruin - Bank of America Rachel Vatnsdal - J.P. Morgan Puneet Souda - Leerink Partners Eve Burstein - Bernstein Operator Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientif ...
Thermo Fisher Scientific Inc. (TMO) Morgan Stanley 21st Annual Global Healthcare Conference - (Transcript)
2023-09-13 18:31
Thermo Fisher Scientific Inc. (NYSE:TMO) Morgan Stanley 21st Annual Global Healthcare Conference September 13, 2023 8:50 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive Officer Conference Call Participants Tejas Savant - Morgan Stanley Tejas Savant Hey, everyone. Good morning. Welcome to Day Three of the Morgan Stanley Healthcare Conference. I'm Tejas Savant and I cover the Life Science Tools and Diagnostics sector at Morgan Stanley. Before we kick it off, just some importan ...
Thermo Fisher Scientific Inc. (TMO) Handelsbanken 3rd Annual Life Science Innovation Day (Transcript)
2023-08-30 15:43
Thermo Fisher Scientific Inc. (NYSE:TMO) Handelsbanken 3rd Annual Life Science Innovation Day August 30, 2023 10:00 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive Officer Conference Call Participants Mattias Häggblom - Handelsbanken Mattias Häggblom So good morning for those of you joining us in the U.S., and good afternoon for those over in Europe. A warm welcome. My name is Mattias Häggblom, I'm sector head of healthcare research here at Handelsbanken, and it's a great pl ...
Thermo Fisher Scientific(TMO) - 2023 Q2 - Earnings Call Transcript
2023-07-26 15:52
Company Participants Marc Casper - Chairman, President and Chief Executive Officer Conference Call Participants Dan Arias - Stifel Dan Brennan - TD Cowen Rachel Vatnsdal - JPMorgan Operator I would now like to introduce our moderator to the call, Mr. Rafael Tejada, Vice President of Investor Relations. Mr. Tejada, you may now begin the call. Good morning, and thank you for joining us. On the call with me today is Marc Casper, our Chairman, President and Chief Executive Officer, and Stephen Williamson, Senio ...
Thermo Fisher Scientific Inc. (TMO) Bernstein 39th Annual Strategic Decisions Conference - (Transcript)
2023-05-31 19:01
Thermo Fisher Scientific Inc. (NYSE:TMO) Bernstein 39th Annual Strategic Decisions Conference Call May 31, 2023 11:00 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive Officer Conference Call Participants Eve Burstein - Bernstein Eve Burstein All right. Good morning, everyone. Let's go ahead and get started. My name is Eve Burstein, and I'm a new analyst at Bernstein. No relation, even though the names sound similar. Pre-launch, we'll be launching on US life science tools and ...